PENROSE/ST. FRANCIS HEALTHCARE — History
CCN 060031 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$810M
Latest Revenue (FY2022)
+1.4%
Revenue CAGR (3yr)
0.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $787M | $47M | $810M | +1619.2% | +1.4% |
| Operating Expenses | $719M | $781M | $808M | +3.6% | +6.0% |
| Operating Margin | 8.7% | -100.0% | 0.2% | +100.2% | -86.7% |
| Net Income | $68M | $-733M | $1M | +100.2% | -86.5% |
| Licensed Beds | 477 | 481 | 484 | +0.6% | +0.7% |
| Total Patient Days | 113,609 | 123,185 | 118,095 | -4.1% | +2.0% |
| Medicare Day % | 24% | 21% | 21% | -3.0% | -6.4% |
| Medicaid Day % | 26% | 22% | 22% | +1.8% | -8.1% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +2.8% ($787M → $810M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.4%
This Hospital
+7.6%
State Avg
Latest Margin
0.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $821M | -4.1% |
| FY2024 (proj) | $832M | -8.3% |
| FY2025 (proj) | $843M | -12.6% |